Cargando…
Effects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13(*) cells
BACKGROUND & OBJECTIVES: Drug resistance is the primary cause of failure in the treatment of cancers. It has been suggested that the enhancement of DNA repair capability may be responsible for the drug resistance of the tumour cells, and poly(ADP-ribosyl)ation plays an important role in DNA repa...
Autores principales: | Zhang, Jingjing, Kan, Yanyan, Tian, Yongjie, Wang, Zhe, Zhang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705661/ https://www.ncbi.nlm.nih.gov/pubmed/23640560 |
Ejemplares similares
-
Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase
por: Westera, Liset, et al.
Publicado: (2019) -
PARPs and ADP-ribosylation: 60 years on
por: Kraus, W. Lee
Publicado: (2020) -
Truncated PARP1 mediates ADP-ribosylation of RNA polymerase III for apoptosis
por: Chen, Qian, et al.
Publicado: (2022) -
PARP2 mediates branched poly ADP-ribosylation in response to DNA damage
por: Chen, Qian, et al.
Publicado: (2018) -
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
por: Alemasova, Elizaveta E, et al.
Publicado: (2019)